Lv4
563 积分 2021-08-11 加入
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
4天前
已完结
HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
2个月前
已完结
Multiancestry genomic and transcriptomic analysis of gastric cancer
2个月前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
5个月前
已完结
Optimizing the Dose and Schedule of Anti–Vascular Endothelial Growth Factor Antibodies in Non–Small-Cell Lung Cancer
5个月前
已完结
Optimizing the Dose and Schedule of Anti–Vascular Endothelial Growth Factor Antibodies in Non–Small-Cell Lung Cancer
5个月前
已关闭
Optimizing the Dose and Schedule of Anti–Vascular Endothelial Growth Factor Antibodies in Non–Small-Cell Lung Cancer
5个月前
已完结
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
5个月前
已完结
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
6个月前
已完结
皖公网安备34019202002308
